Pulmonary Disease Doctors in Santa Maria, CA Accepting Medicare

3 Pulmonary Disease doctors found. Showing 1 - 3

Dr. Barry Steven Feldman, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 E Church St, Santa Maria, CA 93454 Phone: 805-739-3000    Fax: 970-667-0847

Mudit Dabral, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1505 Shepard Dr, Suite 105, Santa Maria, CA 93454 Phone: 805-928-9770    Fax: 805-928-6350

Dr. Robert L Hinds, D.O. Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1400 E Church St, Santa Maria, CA 93454 Phone: 805-739-3000    Fax: 970-667-0847

News Archive

New CT scan technique can reduce radiation exposure

A CT scan technique that splits a full X-ray beam into thin beamlets can deliver the same quality of image at a much reduced radiation dose, according to a new UCL study.

Peripheral prism glasses provide simple mobility rehabilitation intervention for hemianopia

More than a million Americans suffer from hemianopia, or blindness in one half of the visual field in both eyes as the result of strokes, tumors or trauma. People with hemianopia frequently bump into walls, trip over objects, or walk into people on the side where the visual field is missing.

Orexo AB reports year-end 2009 financial results

Sales of Abstral continue to show robust growth, with royalty revenues rising sharply during the fourth quarter – up threefold from the preceding quarter. Our partner, ProStrakan, launched during 2009 Abstral in UK, Germany, France, Spain and Greece, and product launches in additional markets are imminent. Sales growth confirms that there is a substantial medical requirement in the case of cancer patients suffering from breakthrough pain.

BioSante announces sale of oncolytic virus technology to Cold Genesys

BioSante Pharmaceuticals, Inc., today announced it sold to Cold Genesys, Inc. exclusive, worldwide rights to develop and commercialize its oncolytic virus technology. The technology includes CG0070, a replication-competent adenovirus that has completed a Phase I clinical trial for treatment of superficial bladder cancer. In exchange for the technology, BioSante received a 19.9 percent ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and royalty payments.

Medicare system aimed at improving care, lowering costs may not be having as much impact as thought

As the Medicare system seeks to improve the care of older adults while also keeping costs from growing too fast, a new University of Michigan study suggests that one major effort may not be having as much of an impact as hoped.

Read more Medical News

› Verified 8 days ago